{"id":"https://openalex.org/W2889851397","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps7569","title":"KI intolerance study: A phase 2 study to assess the safety and efficacy of TGR-1202 in pts with chronic lymphocytic leukemia (CLL) who are intolerant to prior BTK or PI3K-delta inhibitor therapy.","display_name":"KI intolerance study: A phase 2 study to assess the safety and efficacy of TGR-1202 in pts with chronic lymphocytic leukemia (CLL) who are intolerant to prior BTK or PI3K-delta inhibitor therapy.","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2889851397","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps7569","mag":"2889851397"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.tps7569","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps7569","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps7569","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035507649","display_name":"Colleen Dorsey","orcid":"https://orcid.org/0000-0003-0486-9910","observed_orcids":["https://orcid.org/0000-0003-0486-9910"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Dorsey","raw_affiliation_strings":["Abramson Cancer Center, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, Philadelphia, PA;","institution_ids":["https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030596983","display_name":"Dana Paskalis","orcid":"https://orcid.org/0000-0003-3840-0504","observed_orcids":["https://orcid.org/0000-0003-3840-0504"]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana Paskalis","raw_affiliation_strings":["TG Therapeutics, Inc., Manhattan, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Inc., Manhattan, NY;","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042332348","display_name":"Danielle M. Brander","orcid":"https://orcid.org/0000-0002-9581-2807","observed_orcids":["https://orcid.org/0000-0002-9581-2807"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle M. Brander","raw_affiliation_strings":["Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001204133","display_name":"Frederick Lansigan","orcid":"https://orcid.org/0000-0001-6027-3359","observed_orcids":["https://orcid.org/0000-0001-6027-3359"]},"institutions":[{"id":"https://openalex.org/I1289422878","display_name":"Dartmouth\u2013Hitchcock Medical Center","ror":"https://ror.org/00d1dhh09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I107672454","https://openalex.org/I1289422878","https://openalex.org/I4390039337"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frederick Lansigan","raw_affiliation_strings":["Dartmouth-Hitchcock Medical Center, Lebanon, NH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dartmouth-Hitchcock Medical Center, Lebanon, NH;","institution_ids":["https://openalex.org/I1289422878"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055100327","display_name":"Paul M. Barr","orcid":"https://orcid.org/0000-0002-9733-401X","observed_orcids":["https://orcid.org/0000-0002-9733-401X"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul M. Barr","raw_affiliation_strings":["Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY;","institution_ids":["https://openalex.org/I28792581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010100538","display_name":"Nicole Lamanna","orcid":"https://orcid.org/0000-0003-3331-9491","observed_orcids":["https://orcid.org/0000-0003-3331-9491"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Lamanna","raw_affiliation_strings":["New York-Presbyterian, Columbia University Medical Center, Manhasset, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York-Presbyterian, Columbia University Medical Center, Manhasset, NY;","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082606841","display_name":"Bruce D. Cheson","orcid":"https://orcid.org/0000-0001-9255-7655","observed_orcids":["https://orcid.org/0000-0001-9255-7655","https://orcid.org/0000-0002-6246-4308"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce D. Cheson","raw_affiliation_strings":["Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC;","institution_ids":["https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028299420","display_name":"Jeffrey J. Pu","orcid":"https://orcid.org/0000-0001-7498-3159","observed_orcids":["https://orcid.org/0000-0001-7498-3159"]},"institutions":[{"id":"https://openalex.org/I4405268258","display_name":"Penn State Cancer Institute","ror":"https://ror.org/00bzx1854","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405268258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey J. Pu","raw_affiliation_strings":["Penn State Hershey Cancer Institute, Hershey, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State Hershey Cancer Institute, Hershey, PA;","institution_ids":["https://openalex.org/I4405268258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025465348","display_name":"Marshall T. Schreeder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118515","display_name":"Clearview Cancer Institute","ror":"https://ror.org/020cs7q41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210118515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marshall T. Schreeder","raw_affiliation_strings":["Clearview Cancer Institute, Huntsville, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clearview Cancer Institute, Huntsville, AL;","institution_ids":["https://openalex.org/I4210118515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040412322","display_name":"John M. Pagel","orcid":"https://orcid.org/0000-0001-5745-8125","observed_orcids":["https://orcid.org/0000-0001-5745-8125","https://orcid.org/0000-0003-2875-4878"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Pagel","raw_affiliation_strings":["Swedish Cancer Institute, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Cancer Institute, Seattle, WA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074058246","display_name":"Peter Sportelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Sportelli","raw_affiliation_strings":["TG Therapeutics, Inc., New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Inc., New York, NY;","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049854640","display_name":"Molly J. Fanning","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Molly J Fanning","raw_affiliation_strings":["Abramson Cancer Center, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, Philadelphia, PA;","institution_ids":["https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007928824","display_name":"Hari P. Miskin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hari P. Miskin","raw_affiliation_strings":["TG Therapeutics, Inc., New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Inc., New York, NY;","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010208496","display_name":"Tracey Zimmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810409","display_name":"Hospital of the University of Pennsylvania","ror":"https://ror.org/02917wp91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799810409","https://openalex.org/I4210143392"]},{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tracey Zimmer","raw_affiliation_strings":["Abfamson Cancer Center of the Hospital of the University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abfamson Cancer Center of the Hospital of the University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I2799810409","https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040808358","display_name":"Kristy M. Walsh","orcid":"https://orcid.org/0000-0003-0229-5431","observed_orcids":["https://orcid.org/0000-0003-0229-5431"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristy Walsh","raw_affiliation_strings":["Abramson Cancer Center, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, Philadelphia, PA;","institution_ids":["https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080630441","display_name":"Stephen J. Schuster","orcid":"https://orcid.org/0000-0002-3376-8978","observed_orcids":["https://orcid.org/0000-0002-3376-8978"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen J. Schuster","raw_affiliation_strings":["Abramson Cancer Center, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, Philadelphia, PA;","institution_ids":["https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023609359","display_name":"Eline T. Luning Prak","orcid":"https://orcid.org/0000-0002-9478-9211","observed_orcids":["https://orcid.org/0000-0002-9478-9211"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eline T. Luning-Prak","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061994382","display_name":"E. Paul Wileyto","orcid":"https://orcid.org/0000-0002-4389-1128","observed_orcids":["https://orcid.org/0000-0002-4389-1128"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Paul Wileyto","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108828168","display_name":"Michael Weiss","orcid":"https://orcid.org/0009-0006-7005-273X","observed_orcids":["https://orcid.org/0009-0006-7005-273X"]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael S. Weiss","raw_affiliation_strings":["TG Therapeutics, Inc., New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Inc., New York, NY;","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083072418","display_name":"Anthony R. Mato","orcid":"https://orcid.org/0000-0001-8724-1875","observed_orcids":["https://orcid.org/0000-0001-8724-1875"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony R. Mato","raw_affiliation_strings":["Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"TPS7569","last_page":"TPS7569"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.921999990940094},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.7319999933242798},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8019999861717224},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.6380000114440918},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.48100000619888306},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5210000276565552},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7239999771118164},{"id":"https://openalex.org/keywords/heme-toxicity","display_name":"heme toxicity","score":0.7639999985694885},{"id":"https://openalex.org/keywords/relapsed-refractory-cll","display_name":"relapsed/refractory CLL","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8451575636863708},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6470012068748474},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6075692772865295},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.527096152305603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5263563394546509},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.45810699462890625},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.43727195262908936},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.4294625520706177},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.42668667435646057},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42554765939712524},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33079689741134644},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2899955213069916},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.1724972426891327}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.tps7569","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps7569","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.tps7569","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2890142689","https://openalex.org/W2951135765","https://openalex.org/W2555117288","https://openalex.org/W2599246531","https://openalex.org/W3108843223","https://openalex.org/W2593204692","https://openalex.org/W2527638889","https://openalex.org/W2623436903","https://openalex.org/W2907555512","https://openalex.org/W2522923744"],"abstract_inverted_index":{"TPS7569":[0],"Background:":[1],"Although":[2],"kinase":[3],"inhibitor":[4,77],"(KI)":[5],"therapies,":[6],"such":[7],"as":[8,94,139],"ibrutinib,":[9],"are":[10,132,202,238,283],"generally":[11],"well":[12],"tolerated,":[13],"intolerance":[14],"is":[15,71,83,117,137,218],"the":[16,122],"most":[17],"common":[18],"reason":[19],"for":[20,192,249],"discontinuation":[21],"(d/c)":[22],"in":[23,96,128,269],"practice":[24],"(~50%,":[25],"Mato":[26],"et":[27,41,106],"al,":[28,42,107],"Blood":[29],"2016).":[30,109],"Additionally":[31],"KI":[32,58,133,135,169,188,257],"interruptions":[33],"(\u2265":[34],"8":[35],"days)":[36],"can":[37],"shorten":[38],"OS":[39],"(Barr":[40],"ASCO":[43,108],"2015).":[44],"Fortunately,":[45],"data":[46],"suggest":[47],"that":[48],"KIs":[49],"have":[50,296],"non-overlapping":[51],"toxicity":[52,166,211],"profiles.":[53],"Therefore,":[54],"pts":[55,104,130,201,265,285,295],"who":[56,131],"d/c":[57,87,174,191],"due":[59,89],"to":[60,90,120,168,179,184,228,241,252,289],"intolerance,":[61],"with":[62,78,85,156,204,256,273,286,301],"ongoing":[63],"CLL":[64,129],"response,":[65,226],"represent":[66],"an":[67,97],"unmet":[68],"need.":[69],"TGR-1202":[70,82,127,185,205,232],"a":[72,86],"next":[73],"generation,":[74],"highly-specific":[75],"PI3K-delta":[76],"nanomolar":[79],"inhibitory":[80],"potency.":[81],"well-tolerated":[84],"rate":[88],"AEs":[91],"of":[92,101,126,225,278],"8%":[93],"demonstrated":[95],"integrated":[98],"safety":[99,123,233],"analysis":[100],"165":[102],"treated":[103,203,300],"(Burris":[105],"Methods:":[110],"A":[111],"phase":[112],"2":[113,146,148],"investigator":[114],"initiated":[115],"study":[116,213,216,281],"being":[118],"conducted":[119],"assess":[121],"and":[124,231,246,299],"activity":[125],"intolerant.":[134],"Intolerance":[136],"defined":[138],"\u2265":[140,145,151,161,193],"1":[141,152,162,182],"Gr":[142,147,153,163,181],"3":[143,154],"or":[144,158,212],"non-heme":[149],"toxicities,":[150],"neutropenia":[155],"infection":[157],"fever,":[159],"and/or":[160,171],"4":[164],"heme":[165],"leading":[167],"(BTK":[170],"PI3K":[172],"inhibitor)":[173],"(Table).":[175],"Toxicities":[176],"must":[177,189],"resolve":[178],"\u2264":[180],"prior":[183,240],"dosing.":[186],"Prior":[187],"be":[190,267,290],"14":[194],"days":[195,245],"without":[196],"progression":[197],"(PD).":[198],"All":[199],"eligible":[200,264],"(800mg":[206],"oral":[207],"daily)":[208],"until":[209],"PD,":[210],"conclusion.":[214],"Primary":[215],"endpoint":[217],"PFS.":[219],"Secondary":[220],"endpoints":[221],"include":[222],"ORR,":[223],"duration":[224],"time":[227],"treatment":[229],"failure":[230],"profile.":[234],"Peripheral":[235],"blood":[236],"samples":[237],"collected":[239],"TGR-1202,":[242],"after":[243],"28":[244],"at":[247],"PD":[248],"correlative":[250],"analyses":[251],"identify":[253],"markers":[254],"associated":[255],"intolerance.":[258],"The":[259],"trial":[260,304],"commenced":[261],"10/1/2016.":[262],"55":[263],"will":[266],"enrolled":[268,298],"approximately":[270],"12":[271],"months":[272,275],"24":[274],"follow-up.":[276],"As":[277],"1/2017,":[279],"10":[280,287,294],"sites":[282],"enrolling":[284],"more":[288],"activated.":[291],"To":[292],"date,":[293],"been":[297],"TGR-1202.":[302],"Clinical":[303],"information:":[305],"NCT02742090.":[306],"[Table:":[307],"see":[308],"text]":[309]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-09-27T00:00:00"}